Ruplizumab (Anti-TNFSF5 / CD40L / CD154)

Ruplizumab (Anti-TNFSF5 / CD40L / CD154) is a humanized monoclonal antibody targeting CD40L(TNF Receptor). It has the potential for systemic lupus erythematosus disease research. MW :145.68 KD.
Supplier Selleck Chemicals
Product # A3100
Sku # A3100-1mg*25
Pricing 1mg*25, $2970.00
Feedback